Zhi-Qiang Wang Selected Research

Catenins

1/2022	SKI knockdown suppresses apoptosis and extracellular matrix degradation of nucleus pulposus cells via inhibition of the Wnt/β-catenin pathway and ameliorates disc degeneration.
1/2018	Expression and clinical significance of HOXA5, E-cadherin, and β-catenin in cervical squamous cell carcinoma.
1/2014	Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-Qiang Wang Research Topics

Disease

75	Neoplasms (Cancer) 03/2024 - 11/2004
31	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 09/2009
25	Neoplasm Metastasis (Metastasis) 05/2024 - 06/2012
19	Stomach Neoplasms (Stomach Cancer) 09/2023 - 10/2010
13	Nasopharyngeal Carcinoma 11/2023 - 08/2016
11	Esophageal Squamous Cell Carcinoma 01/2024 - 06/2012
8	Adenocarcinoma 01/2019 - 09/2009
7	Lymphatic Metastasis 01/2023 - 06/2012
5	Inflammation (Inflammations) 10/2022 - 10/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2006
5	Infections 08/2021 - 08/2010
4	Hemorrhage 10/2022 - 09/2010
4	Pain (Aches) 10/2022 - 06/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2012
4	Carcinoma (Carcinomatosis) 11/2016 - 11/2012
4	Myopathy with Abnormal Lipid Metabolism 07/2016 - 06/2011
3	Sepsis (Septicemia) 12/2023 - 09/2010
3	Necrosis 10/2023 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2017
3	Neutropenia 11/2022 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2017
3	Melanoma (Melanoma, Malignant) 11/2020 - 05/2009
3	Disease Progression 01/2020 - 12/2006
3	Schizophrenia (Dementia Praecox) 07/2019 - 01/2017
3	Acidosis 01/2019 - 01/2018
3	Rheumatoid Arthritis 10/2018 - 01/2018
3	Hypersensitivity (Allergy) 01/2018 - 01/2010
3	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 07/2016 - 06/2011
3	Multiple Myeloma 01/2016 - 10/2010
3	Carcinogenesis 12/2015 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 09/2012
2	Hypertension (High Blood Pressure) 10/2023 - 09/2022
2	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 01/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2022 - 02/2012
2	Leukopenia 11/2022 - 08/2016

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2010
12	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2013
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 09/2009
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 09/2009
7	Messenger RNA (mRNA)IBA 01/2018 - 10/2010
7	EnzymesIBA 01/2018 - 10/2003
6	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 08/2016
5	Cetuximab (Erbitux)FDA Link 05/2024 - 01/2011
5	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 09/2009
5	Immune Checkpoint InhibitorsIBA 11/2023 - 11/2019
5	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2017
5	Cadherins (E-Cadherin)IBA 01/2023 - 06/2012
5	AcidsIBA 10/2018 - 01/2015
5	Carcinoembryonic AntigenIBA 01/2014 - 09/2009
4	Bevacizumab (Avastin)FDA Link 03/2024 - 12/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 08/2016
4	toripalimabIBA 11/2023 - 01/2020
4	apatinibIBA 10/2023 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2013
4	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2016
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2006
3	Monoclonal AntibodiesIBA 03/2024 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024 - 11/2004
3	camrelizumabIBA 10/2023 - 01/2020
3	VimentinIBA 01/2023 - 06/2012
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 02/2012
3	CateninsIBA 01/2022 - 01/2014
3	LigandsIBA 01/2020 - 06/2004
3	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2010
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 05/2014
3	LipidsIBA 01/2018 - 01/2016
3	CytokinesIBA 01/2018 - 06/2004
3	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2014
3	Therapeutic UsesIBA 02/2013 - 10/2007
3	Superoxide DismutaseIBA 09/2004 - 10/2003
3	Superoxides (Superoxide)IBA 09/2004 - 10/2003
2	ChromatinIBA 03/2024 - 05/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 06/2011
2	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 11/2023 - 01/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023 - 02/2012
2	AntioxidantsIBA 05/2023 - 09/2012
2	Caspase 3 (Caspase-3)IBA 05/2023 - 01/2018
2	DesminIBA 01/2023 - 01/2007
2	human ERBB2 proteinIBA 01/2023 - 05/2014
2	taxaneIBA 11/2022 - 01/2019
2	PlatinumIBA 11/2022 - 01/2014

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 05/2024 - 09/2006
30	Therapeutics 01/2023 - 09/2006
8	Radiotherapy 11/2023 - 08/2010
6	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2015
6	Esophagectomy 01/2018 - 05/2014
5	Induction Chemotherapy 01/2024 - 01/2019
4	Chemoradiotherapy 11/2023 - 01/2019
4	Re-Irradiation 10/2023 - 08/2016
4	Length of Stay 10/2022 - 03/2015
4	Adjuvant Chemotherapy 01/2022 - 01/2014
4	Hepatectomy 02/2021 - 10/2017
4	Immunotherapy 01/2021 - 01/2018
4	Gastrectomy 01/2019 - 02/2011
3	Salvage Therapy 01/2021 - 09/2009
3	Metastasectomy 01/2019 - 01/2017
3	Thoracotomy 01/2018 - 11/2016
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 01/2022
2	Osteotomy 11/2022 - 10/2022
2	Pedicle Screws 10/2022 - 06/2021